Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

4,534 questions · 5,247 findings · 456 reviews

No studies found 1,142 · 21.8%GRADE not reported 1,503 · 28.6%Very low 1,040 · 19.8%Low 869 · 16.6%Moderate 554 · 10.6%High 139 · 2.6%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Retzius‐sparing RALP vs standard RALP

Urinary continence within 1 week after catheter removal MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer

Retzius‐sparing RALP probably leads to higher urinary continence within 1 week after catheter removal MCID: 5%… compared with standard RALP (moderate certainty).

1 finding from 1 review

Retzius‐sparing RALP vs standard RALP

Urinary continence 3 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer

Retzius‐sparing RALP may leads to higher urinary continence 3 months after surgery MCID: 5% absolute difference compared with standard RALP (low certainty).

1 finding from 1 review

Retzius‐sparing RALP vs standard RALP

Serious adverse events · men (ages > 18 years) with clinically localized prostate cancer

It is very uncertain whether retzius‐sparing RALP changes serious adverse events compared with standard RALP (very low certainty).

1 finding from 1 review

Retzius‐sparing RALP vs standard RALP

Urinary continence 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer

Retzius‐sparing RALP showed no clear difference in urinary continence 12 months after surgery MCID: 5% absolute… compared with standard RALP (moderate certainty).

1 finding from 1 review

Retzius‐sparing RALP vs standard RALP

Potency 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer

It is very uncertain whether retzius‐sparing RALP changes potency 12 months after surgery MCID: 5% absolute difference compared with standard RALP (very low certainty).

1 finding from 1 review

Retzius‐sparing RALP vs standard RALP

Positive surgical margins MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer

Retzius‐sparing RALP may leads to higher positive surgical margins MCID: 5% absolute difference compared with standard RALP (low certainty).

1 finding from 1 review

Retzius‐sparing RALP vs standard RALP

Biochemical recurrence‐free survival · men (ages > 18 years) with clinically localized prostate cancer

It is very uncertain whether retzius‐sparing RALP changes biochemical recurrence‐free survival compared with standard RALP (very low certainty).

1 finding from 1 review

Digital targeted client communication via mobile devices vs digital, non‐targeted communication

Health status and well‐being ‐ STI incidence (chlamydia) · Adolescents and youth age 14 to 24 years

Digital targeted client communication via mobile devices showed no clear difference in health status and well‐being ‐ STI incidence (chlamydia) compared with digital, non‐targeted communication (low certainty).

1 finding from 1 review

Digital targeted client communication via mobile devices vs digital, non‐targeted communication

Health behaviour change ‐ Condom use · Adolescents and youth age 14 to 24 years

It is very uncertain whether digital targeted client communication via mobile devices changes health behaviour change ‐ Condom use compared with digital, non‐targeted communication (very low certainty).

1 finding from 1 review

Digital targeted client communication via mobile devices vs digital, non‐targeted communication

Health behaviour change ‐ Contraceptive use at last sex · Adolescents and youth age 14 to 24 years

It is very uncertain whether digital targeted client communication via mobile devices changes health behaviour change ‐ Contraceptive use at last sex compared with digital, non‐targeted communication (very low certainty).

1 finding from 1 review

Digital targeted client communication via mobile devices vs digital, non‐targeted communication

Health service utilization ‐ Clinic attendance for STI/HIV testing · Adolescents and youth age 14 to 24 years

Digital targeted client communication via mobile devices may leads to higher health service utilization ‐ Clinic attendance for STI/HIV testing… compared with digital, non‐targeted communication (low certainty).

1 finding from 1 review

Digital targeted client communication via mobile devices vs standard skin care or no skin care intervention

Health behaviour change ‐ Condom use · Adolescents and youth age 14 to 24 years

It is very uncertain whether digital targeted client communication via mobile devices changes health behaviour change ‐ Condom use compared with standard care or no intervention (very low certainty).

1 finding from 1 review

Digital targeted client communication via mobile devices vs digital, non‐targeted communication

Unintended consequences · Adolescents and youth age 14 to 24 years

Digital targeted client communication via mobile devices may leads to lower unintended consequences compared with digital, non‐targeted communication (low certainty).

1 finding from 1 review